Literature DB >> 8394332

Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins.

L Stephens1, T Jackson, P T Hawkins.   

Abstract

Formylated Met-Leu-Phe (fMLP), platelet-activating factor (PAF), ATP, and various nonhydrolyzable guanine nucleotides stimulated accumulation of phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) in intact human neutrophils. A protocol was devised to selectively inhibit the capacity of the nucleotide-sensitive receptors to elicit accumulation of PtdIns (3,4,5)P3. This enabled study of the regulation of phosphoinositide 3OH-kinase (PI3K) activities in permeabilized neutrophils free from interference due to activation of cell-surface nucleotide receptors. FMLP, PAF, and nonhydrolyzable GTP analogues stimulated an increase in the concentration, and rate of synthesis, of PtdIns(3,4,5)P3 in permeabilized neutrophils by increasing the rate of a PtdIns(4,5)P2-directed PI3K-catalyzed reaction. A number of characteristics of these responses, including their relative sensitivities to inhibition by pertussis toxin and guanosine 5'-beta-(thio)diphosphate, suggested that fMLP and PAF increased this PI3K activity via the actions of heterotrimeric G-proteins. Basal and guanosine 5'-gamma-(thio)triphosphate/fMLP-stimulated increases in PI3K activity were resistant to changes in free calcium concentrations, staurosporine, acute treatment with phorbol esters, and evidently to permeabilization. This, in conjunction with other work, indicates that the PAF and fMLP-induced increase in PtdIns(4,5)P2-directed PI3K activity is not being produced via activation of a currently defined G-protein regulated effector enzyme, or a protein tyrosine kinase coordinated mechanism of a type already known to regulate PI3K activities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394332

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Co-operation of phosphatidylinositol transfer protein with phosphoinositide 3-kinase gamma in the formylmethionyl-leucylphenylalanine-dependent production of phosphatidylinositol 3,4,5-trisphosphate in human neutrophils.

Authors:  G Kular; M Loubtchenkov; P Swigart; J Whatmore; A Ball; S Cockcroft; R Wetzker
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

2.  Metabolic evidence for PtdIns(4,5)P2-directed phospholipase C in permeabilized plant protoplasts.

Authors:  C A Brearley; P N Parmar; D E Hanke
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

3.  Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes.

Authors:  M Thelen; M P Wymann; H Langen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Mapping of the C5a receptor signal transduction network in human neutrophils.

Authors:  A M Buhl; N Avdi; G S Worthen; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Activation of phosphatidylinositol 4,5-bisphosphate supply by agonists and non-hydrolysable GTP analogues.

Authors:  L Stephens; T R Jackson; P T Hawkins
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

6.  EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase.

Authors:  K Akimoto; R Takahashi; S Moriya; N Nishioka; J Takayanagi; K Kimura; Y Fukui; S i Osada; K Mizuno; S i Hirai; A Kazlauskas; S Ohno
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

7.  Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity.

Authors:  M Russell; S Winitz; G L Johnson
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Autophosphorylation of serine 608 in the p85 regulatory subunit of wild type or cancer-associated mutants of phosphoinositide 3-kinase does not affect its lipid kinase activity.

Authors:  Meredith J Layton; Mirette Saad; Nicole L Church; Richard B Pearson; Christina A Mitchell; Wayne A Phillips
Journal:  BMC Biochem       Date:  2012-12-27       Impact factor: 4.059

9.  Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.

Authors:  S Ishii; T Kuwaki; T Nagase; K Maki; F Tashiro; S Sunaga; W H Cao; K Kume; Y Fukuchi; K Ikuta; J Miyazaki; M Kumada; T Shimizu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

10.  The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.

Authors:  Alexandre Arcaro; Ana S Guerreiro
Journal:  Curr Genomics       Date:  2007-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.